SBIR/STTR Research Award

A System to Optically Determine the Absolute Membrane Potential in Human iPSCD Cardiac Myocytes

Award identifier a56a5ba5f52b0b96e5b60e43dc6705b326b8a6696c359a91190a276fdd93b88cAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$250,000

Program and phase

SBIR · Phase I

Award year

2020

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Cytocybernetics Inc
Proposal award date
2020-07-09
Contract end date
2021-08-31
UEI
G69NH6PMLT75
Solicitation number
PA19-272
Topic code
NHLBI

Research abstract

Optical assays are a powerful tool in cellular electrophysiology. However, currently-available approaches have not reached their full potential. The major limitation of existing optical systems is that they are unable to determine the absolute voltage in the cell. Current commercial approaches report only qualitative relative changes in voltage, andamp; there is no information on absolute resting potential, diastolic potential, or action potential amplitude. Prior research attempts to develop absolute voltage reports have been unsuccessful. In addition, currently available voltage- sensitive dyes (VSDs) offer a very limited experimental duration (typically andlt; 30 min) dyes due to: 1) high washout andamp; internalization rates, which removes them from the electrically active cell membrane; 2) high photo-toxicity, which reduces the possible exposure time for measurements; andamp; 3) acute dye toxicity, which limits membrane loading andamp; illumination, resulting in small signals andamp; low signal to noise ratio.This proposal overcomes these 2 major obstacles to develop andamp; optimize our novel system which combines our VSDs andamp; our unique andamp; robust optical andamp; analytical system which determines absolute membrane potential. Our integrated quantitative Optical Electrophysiology (qOEP) system consists of our patented long lasting VSDs, optimized experimental protocols, optical detection system, andamp; analytical software. Our VSDs, which operate in the red/NIR spectral range, have reduced acute chemical andamp; photo-toxicity, increased sensitivity, andamp; slower washout/ internalization rate. This gives them the ability to be used in experiments up to 4 hours. This dramatic improvement revolutionizes the types of experiment which can be performed. Specifically, slower internalization rate gives the experimenter time to calibrate the VSD, so that the measured light intensity can be directly correlated with transmembrane potential. The spectral properties andamp; stability of this new generation of VSDs has been combined with advances in electronics andamp; circuitry that increase signal sensitivity andamp; allow for qOEP. Dye performance andamp; signal processing are species andamp; organ/cell type-specific. These systems have high degrees of cellular heterogeneity andamp; connective tissue relative to cultured cells. To develop a consistent system we will optimize our qOEP system specifically for work with electrically syncytial preparations of induced pluripotent stem cell derived (IPSCD) cardiac myocytes. The goal is to optimize a cell system (stem cell derived cardiac myocytes) andamp; the dyes to make an integrated optical system that makes qOEP available to almost any lab. This transformation will be similar to the way that the advent of molecular biology kits made complex molecular biological techniques accessible to all. The long term commercial opportunity is in cardiac safety screening to determine the arrhythmogenic potential of new drug candidates in stem cell derived cardiac myocytes. Our novel system has the potential to have significant impact in both the financial andamp; human health aspects of drug development. Successful completion of Phase I will result in a system consisting of sensors, dyes, illumination sources, andamp; software that can be used for beta testing in Phase II. In Phase II we will develop software, support, packaging andamp; optimized hardware for a turn-key commercial system.Optical imaging of electrical activity in cells enables the monitoring of cellular electrical activity to be observed without the use of cumbersome, difficult and potentially damaging mechanical electrodes. However, current optical methods are hampered by the unstable and damaging nature of currently available voltage sensitive dyes, and they do not give information on absolute membrane potential. This project will deliver a simple to use quantitative optical electrophysiology (qOEP) system, with long lasting dyes, a novel optical detector, and software to determine actual membrane potential (during an action potential and at rest) optimized for human induced pluripotent stem cell derived cardiac myocytes, which will result in affordable, stable, reproducible, reliable, high quality optical recordings suitable for identifying electrical activity in cardiac myocytes.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

9 SBIR/STTR records share this UEI (2015–2025). Reported award amounts total $6,874,751. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, National Science Foundation

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.